Importance of Influenza Anti-Hemagglutinin Antibodies During the SARS-CoV-2 Pandemic in the 2019/2020 Epidemic Season in Poland

Lidia B. Brydak; Karol Szymański; Katarzyna Kondratiuk; Anna Poznańska; Adam Kolondra; Ewelina Hallmann

doi:10.12659/MSM.936495

20 May 2022 : Clinical Research

Importance of Influenza Anti-Hemagglutinin Antibodies During the SARS-CoV-2 Pandemic in the 2019/2020 Epidemic Season in Poland

Lidia B. Brydak^1ADEFG, Karol Szymański^1BF, Katarzyna Kondratiuk^1BF, Anna Poznańska^2CDE, Adam Kolondra^1B, Ewelina Hallmann^1BDEF*

DOI: 10.12659/MSM.936495

Med Sci Monit 2022; 28:e936495

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 3 Response rate for anti-A/Kansas/14/2017 (H3N2) antibodies by age of respondents and their influenza vaccination status in the 2019/2020 season.

Back to the Article

Importance of Influenza Anti-Hemagglutinin Antibodies During the SARS-CoV-2 Pandemic in the 2019/2020 Epidemic Season in Poland

Your Privacy